AstraZeneca is acquiring Belgian biotech EsoBiotec for up to $1 billion to enhance its cancer therapy portfolio. EsoBiotec's innovative ENaBL platform enables rapid, cost-effective cell therapy...
Gene therapies, including CAR-T, are revolutionizing medicine, with advancements like CRISPR expanding possibilities. Spain excels in transplants and CAR-T access, doubling authorized centers since 2023. Academic...